Roles of Inflammation and Depression in the Development of Gestational Diabetes
- 134 Downloads
The purpose of this review was to critically assess the available data regarding associations between inflammation and symptoms of depression among perinatal women, and to explore whether there is support for the hypothesis that inflammation associated with depression can represent a precipitating insult for the development of gestational diabetes, a known inflammatory morbidity of pregnancy.
Primary data papers that explored associations between inflammatory biomarkers and depressive symptoms in perinatal women were obtained via targeted searches of PubMed and Google Scholar, and via citations within relevant data papers and review articles.
Twenty primary data papers were found that attempted to associate levels of inflammatory biomarkers with depressive symptomatology in the perinatal period. Results from these papers were heterogeneous and did not describe a reproducible inflammatory profile of perinatal depression.
Depression in the perinatal period is a common disorder; however, available data do not indicate that there is a specific inflammatory picture associated with perinatal depression. We suggest that perinatal depression may be a heterogeneous construct, and that inflammation may be relevant to it in the context of other inflammatory morbidities of pregnancy. There is some circumstantial support for the hypothesis that inflammation associated with depression may contribute to risk for gestational diabetes, but as yet, no direct tests of this hypothesis have been published.
KeywordsInflammation Gestational diabetes Perinatal depression Postpartum depression Cytokine Insulin
Compliance with Ethical Standards
Conflict of Interest
Dr. Robakis, Dr. Aasly, Dr. Williams, and Dr. Clark have nothing to declare. Dr. Rasgon was a consultant for Sunovion.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 19.Kashani L, Omidvar T, Farazmand B, Modabbernia A, Ramzanzadeh F, Tehraninejad ES, et al. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology. 2013;38(6):767–76.PubMedCrossRefGoogle Scholar
- 23.Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51(6):1884–8.PubMedCrossRefGoogle Scholar
- 32.Taylor VH, MacQueen GM. The role of adipokines in understanding the associations between obesity and depression. J Obes. 2010;2010(748048):6.Google Scholar
- 36.Köhler, C.A., Freitas, T.H., Stubbs, B. et al. Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol. 2017; 1–12. https://doi.org/10.1007/s12035-017-0632-1.
- 38.• Raison CL, Miller AH. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry. 2013;18(1):15. This review summarizes evidence for a bidirectional, functional linkage between the physiology of inflammation and the symptoms of depression. PubMedCrossRefGoogle Scholar
- 42.Ruocco MG, Chaouat G, Florez L, Bensussan A, & Klatzmann D. Regulatory T-cells in pregnancy: historical perspective, state of the art, and burning questions. Front Immunol. 2014;5.Google Scholar
- 45.• Griffith OW, Chavan AR, Protopapas S, Maziarz J, Romero R, & Wagner GP. Embryo implantation evolved from an ancestral inflammatory attachment reaction. Proceedings of the National Academy of Sciences, 2017;114(32):E6566–E6575. This work provides molecular evidence that ancient inflammatory signals were repurposed to facilitate the process of embryo implantation in mammals. Google Scholar
- 59.Scrandis DA, Langenberg P, Tonelli LH, Sheikh TM, Manogura AC, Alberico LA, et al. Prepartum depressive symptoms correlate positively with C-reactive protein levels and negatively with tryptophan levels: a preliminary report. Int J Child Health Hum Dev. 2008;1(2):167.PubMedPubMedCentralGoogle Scholar
- 68.Skalkidou A, Sylvén SM, Papadopoulos FC, Olovsson M, Larsson A, Sundström-Poromaa I. Risk of postpartum depression in association with serum leptin and interleukin-6 levels at delivery: a nested case–control study within the UPPSAT cohort. Psychoneuroendocrinology. 2009;34(9):1329–37.PubMedCrossRefGoogle Scholar
- 73.• PACT Consortium. Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry. 2015;2(1):59–67. This study analyzes the clinical characteristics of a large number of women with postpartum depression, identifying three subtypes with distinct patterns of onset, timing, and severity. CrossRefGoogle Scholar
- 80.Morrison C, McCook JG, Bailey BA. First trimester depression scores predict development of gestational diabetes mellitus in pregnant rural Appalachian women. J Psychosom Obstet Gynaecol. 2015;1–5.Google Scholar
- 102.Ozgu-Erdinc AS, Yilmaz S, Yeral MI, Seckin KD, Erkaya S, Danisman AN. Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med. 2015;28(16):1957–62.PubMedCrossRefGoogle Scholar
- 105.Hassiakos D, Eleftheriades M, Papastefanou I, Lambrinoudaki I, Kappou D, Lavranos D, et al. Increased maternal serum interleukin-6 concentrations at 11 to 14 weeks of gestation in low risk pregnancies complicated with gestational diabetes mellitus: development of a prediction model. Horm Metab Res. 2016;48(01):35–41.PubMedGoogle Scholar
- 121.Tang Y, Qiao P, Qu X, Bao Y, Li Y, Liao Y, et al. Comparison of serum vaspin levels and vaspin expression in adipose tissue and smooth muscle tissue in pregnant women with and without gestational diabetes. Clin Endocrinol. 2017;87(4):344–349.Google Scholar
- 129.Lacroix M, Battista MC, Doyon M, Ménard J, Ardilouze JL, Perron P, et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Clin. Chem. Lab. Med. (CCLM), 2013;55(11):1805-1812.Google Scholar
- 130.Thagaard IN, Krebs L, Holm JC, Lange T, Larsen T, & Christiansen M. Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study. Clin Chem Lab Med. 2017.Google Scholar
- 134.Lindsay RS, Loeken MR. Metformin use in pregnancy: promises and uncertainties. Diabetologia. 2017;1–8.Google Scholar